Posted December 6th, 2019 by derek.
Posted November 8th, 2019 by Munley Law.
In September 2019, the FDA issued a warning that the drug Zantac contains a carcinogenic substance called NDMA.
Zantac is a heartburn and acid reflux medication containing the ingredient ranitidine. The FDA warning also applies to generic versions of heartburn medicine containing ranitadine. Ranitidine is available in prescription and over the counter versions.
What is NDMA?
NDMA (N-nitrosodimethylamine) is a chemical present in gasoline, fuels, and industrial lubricants. It is classified as a probable human carcinogen, or cancer-causing substance. The amounts of NDMA found in Zantac pills were 3,000-26,000 times higher than the legal limit. A 2016 study by Stanford University tested ten voluntary subjects and found that after just one 150mg dose of Zantac, users’ urine contained 490 times the FDA’s permissible daily intake of NDMA.
Has Zantac Been Recalled?
Zantac manufacturer Sanofi-Aventis LLC recalled Zantac OTC products in the U.S. […]Read More
Load More Posts